Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)

This study has been terminated.
(This study competed with another VICC study)
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Pierre P. Massion, MD, Vanderbilt-Ingram Cancer Center
ClinicalTrials.gov Identifier:
NCT00898209
First received: May 9, 2009
Last updated: June 23, 2014
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)